11 New Sexual and Reproductive Health Guidelines and Technologies Sharon Phillips, Lisa Thomas, Lale Say 31 May 2013.

Slides:



Advertisements
Similar presentations
Skilled Birth Attendant and Skilled Birth Attendance
Advertisements

FIGO’s Ten Year Commitment to PPH Prevention and Treatment
MEETING HEALTH SYSTEMS CHALLENGES RELATED TO EMERGENCY OBSTETRIC CARE B Subha Sri, MPS Course, July 2010.
MATERNAL HEALTH Some technical aspects ANC, Delivery Care and PNC
Preventing PPH: Community Based Distribution of Misoprostol Harshad Sanghvi Vice President & Medical Director, Jhpiego.
Safe abortion- medical methods of termination, post abortion care and referral, pre and post abortion counseling 27/06/2014.
Pathfinder Continuum of Care for Addressing Post-Partum Hemorrhage (PPH) Dr. Abdelhadi Eltahir, MD, MPH, Senior Advisor for Maternal and Newborn Health,
Reducing Maternal Mortality Due to Postpartum Hemorrhage (PPH)
Maternal and Newborn Health Training Package
Towards National Impact of PPH Prevention: Bangladesh Experience Prof. Dr. Shah Monir Hossain Director General Directorate General of Health Services Ministry.
ASAP Satellite Symposium Safe Abortion in Asia - Making it Work 5th APCRSHR, Beijing Introducing medical abortion into the public sector in Nepal Dr B.
Community interventions; Physiological management of the third stage of labour. Karen Guilliland CEO New Zealand College of Midwives ICM Board Member.
Umbilical cord clamping in term deliveries: the RCOG perspective Dr Anna David Reader and Consultant in Obstetrics and Maternal Fetal Medicine UCL Institute.
RCM Evidence based Guidelines for Midwifery-led Care in Labour Mervi Jokinen Practice and Standards Development Advisor APPG 20 th November 2012.
Optimizing the delivery of key interventions to attain MDGs 4 & 5 through task-shifting (Optimize4MNH) RECOMMENDATIONS for HEALTH PROFESSIONALS A. Metin.
Adapted from JHPIEGO. Active Management of the Third Stage of Labor: Advances in Maternal and Neonatal Health. Available at:
Interventions for Impact in Essential Obstetric and Newborn Care Africa Regional Meeting, 21–25 February 2011 A SSESSING THE Q UALITY OF SERVICES TO PREVENT.
Postpartum Haemorrhage. Definitions Primary PPH – blood loss of 500ml or more within 24hours of delivery. Secondary PPH – significant blood loss between.
Factors Affecting Maternal Mortality (MM) in Turkey and in the World Dr. Yeşim YASİN Spring-2014.
Policies for einc* care. 3.4 million pregnancies occur every year 11 mothers die of pregnancy - related causes everyday Leading cause of maternal deaths:
World Health Organization
Maternal Mortality & the MDGs Deborah Maine Professor, International Health Boston University, School of Public Health.
Third stage of labour Dr.Roaa H. Gadeer MD.
Unsafe Abortion Dr Reza Nasr MD MRCOG DFFP NAIGO Monthly Meeting
Active Management of Third Stage of Labor
Obstetric Haemorrhage. Aims To recognise Obstetric Haemorrhage To recognise Obstetric Haemorrhage To practise the skills needed to respond to a woman.
Max Brinsmead MB BS PhD May 2015 Maternal Mortality.
ANNUAL REPORT 2010 HIGHLIGHTS. It’s a record! The international donor community rallied behind the goals of UNFPA, contributing a record $850 million.
Child Health: How Have We Been Doing; Where to Now? An Update on MDG 4 and 5: Maternal and Child Health By Dr. Mickey Chopra, Chief, Health and Associate.
| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing of delivery and induction.
Misoprostol for the Prevention of Postpartum Hemorrhage Lisa J. Thomas, MD, FACOG Women’s Commission for Refugee Women and Children.
Active Management of the Third Stage of Labor Name of presenter Prevention of Postpartum Hemorrhage Initiative (POPPHI) Project PATH.
PPH Prevention and Management at Health Facilities Jeffrey M. Smith Asia Regional Technical Director AME Regional Meeting Bangkok March 2010.
Child and Adolescent Health and Development RHR RHR Guidance of WHO on safe abortion FIAPAC, Moscow October 28, 2005 G. Lazdane Regional Adviser RHR WHO.
SEVERE ACUTE MATERNAL MORBIDITY/NEAR MISS MATERNAL MORBIDITY Sangeetagupta Seniorconsultant&HOD, Deptt of Obst.&Gynae,ESIPGIMSR,Basaidarapur.
WHO Recommendations for the Prevention of Postpartum Haemorrhage Results from a WHO Technical Consultation – October 18-20, 2006 Deborah Armbruster, POPPHI/PATH.
Postpartum Hemorrhage JEFF YAO ALI SHAHBAZ. “ ” Investing in maternal health is a wise health and economic policy decision. Women are the sole income-earners.
SOCIAL OBSTETRICS Defined as the study of the interplay of social and environmental factors and human reproduction going back to preconceptional.
05_XXX_MM1 Implementing Safe Abortion: technical and policy guidance for health systems Ronnie Johnson, PhD UNDP/UNFPA/WHO/World Bank Special Programme.
XXX_DECRIPT_MON00/1 Quality and impact of Social Science and Operations Research by the Special Programme in Human Reproduction Department of Reproductive.
Tracking Scale Up of Maternal and Newborn Health Interventions Jeffrey M. Smith MCHIP Interventions for Impact in Essential Obstetric and Newborn Care.
Overcoming provider barriers to introduction and sustainability of AMTSL at facilities Susheela M. Engelbrecht PATH / Oxytocin Initiative.
Misoprostol: A Life-Saving Technology Jennifer Blum, MPH.
Maternal Health Supplies in Bangladesh and Uganda Reproductive Health Supplies Coalition 28 May 2010 Elizabeth Leahy Madsen Jennifer Bergeson-Lockwood.
04_DirectorReport_PCC/1 9/2004 Rita Kabra_/1 Access to essential medicines for Maternal and Newborn Health Dr Rita Kabra Making Pregnancy Safer WHO/EDM.
Strategic assessment of policy, quality and access to contraception and abortion services in Macedonia Main findings 2007/08.
Overview of Study Management of the Third Stage of Labor In Uganda.
1 |1 | Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 WHO Recommendations for the.
Active Management of 3rd Stage of Labour
Maternal Health at the District Hospital Family Medicine Specialist CME Oct , 2012 Pakse.
Optimizing the Delivery of Key Maternal and Newborn Interventions through Task Shifting Dr. Salim Sohani, Senior Health Advisor, Canadian Red Cross Ottawa.
Research to evaluate components of AMTSL POPPHI/USAID/WHO Istanbul, Turkey, 4-5 December 2007.
ADDRESSING SEXUAL, REPRODUCTIVE, & MATERNAL HEALTH ISSUES IN THE CONTEXT OF EBOLA A FIELDWORK EXPERIENCE AT THE WORLD HEALTH ORGANIZATION AMY BHOPAL.
Heavy menstrual bleeding Implementing NICE guidance January 2007 NICE clinical guideline 44.
South Sudan Integrated Service Delivery Program Building Capacity for Implementation and Supportive Supervision for PPH prevention Isabella Ochieng, PPH.
Implementing Quality: An introduction to Quality Standards Dr Françoise Cluzeau, Associate Director NICE International Maternal Quality Standards in the.
CAPACITY ENHANCEMENT PROGRAM FOR MIDWIVES ON MATERNAL AND NEWBORN CARE MDG COUNTDOWN:
To AMTSL or Not to AMTSL: That is the Question Deborah Armbruster, Senior Maternal Health and Newborn Advisor Bureau for Global Health, USAID CSHGP’s Partners.
South Sudan Integrated Service Delivery Program PREVENTION OF PPH: AMTSL AT HEALTH FACILITY & MISOPROSTOL AT HOME BIRTH Why a Learning Phase? May 15 th.
CHAPTER 17 Global Health in Reproduction and Infants By: Carol Holtz.
Emergency Obstetric and Newborn Care (EmONC)
MOVING TO ACTION: Identifying Responses.
Medical Abortion at all Gestations
WHO recommendations on interventions to improve preterm birth outcomes
Management of the 3rd stage of Labor
Table of contents 01 The global burden of postpartum haemorrhage 04 What are the updated WHO recommendations? 02 Uterotonics for PPH prevention 05.
Assessing and Monitoring Maternal Health Commodity Security
CONTRACEPTION COUNSELLING AND PROVISION
Geneva 2019 SAFE ABORTION CARE Dr Venkatraman Chandra-Mouli.
Presentation transcript:

11 New Sexual and Reproductive Health Guidelines and Technologies Sharon Phillips, Lisa Thomas, Lale Say 31 May 2013

22 To help people lead healthy sexual and reproductive lives Mission of HRP The attainment by all peoples of the highest possible level of sexual and reproductive health Vision statement

3 Department of Reproductive Health and Research (RHR), including UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP) Marleen Temmerman, Director Global strategies, frameworks and initiatives (ICPD, MDGs, H4+) Partnerships and global advocacy Oversight and coordination of research, research capacity building, work with WHO Regional and Country offices and WHO collaborating centres Biostatistics and data management Programme Management, HRP Trust Fund, HRP direct administrative support Human Reproduction Team Mario Merialdi, Coordinator Contraception / Family planning Reproductive tract and sexually transmitted infections Infertility Women’s health Adolescents and at-Risk Populations Team Lale Say, Coordinator Adolescent sexual and reproductive health Gender-based and sexual violence Harmful practices Sexual and reproductive health in emergencies, conflict, and humanitarian crises, and of other at-risk populations RHR/HRP’s mandate includes : (i) research; (ii) development of new technologies and interventions; (iii) systematic reviews and evidence synthesis; (iv) setting norms, standards and guidelines; (vi) synthesis of global indicators and (vii) national research capacity strengthening. Maternal and Perinatal Health and Preventing Unsafe Abortion Team Metin Gülmezoglu, Coordinator Maternal and perinatal health Prevention of unsafe abortion Pre-conception / pre-pregnancy

44 WHO recommendations for the prevention and treatment of post-partum haemorrhage (PPH)  Since last IAWG  New recommendations on use of oxytocin, misoprostol, cord traction, cord clamping and the non-pneumatic anti-shock garment  Available online and on CD Filename

55 PPH Prevention  Cord traction now optional (based on new evidence)  Prophylactic uterotonics recommended for all women – Oxytocin where available – Other injectable uterotonics or misoprostol where oxytocin not available Filename

66 PPH Treatment  Uterotonics (first choice oxytocin)  Intrauterine balloon tamponnade for persistent bleeding or if uterotonics unavailable  Non-pneumatic anti-shock garment recommended as a temporizing measure while awaiting further care Filename

77 WHO Recommendations for prevention and treatment of pre-eclampsia and eclampsia  Released 2011  New recommendations on use of magnesium sulfate and antihypertensive drugs Filename

88 Prevention and treatment of pre- eclampsia/eclampsia  Magnesium sulfate is the drug of choice for treatment of eclampsia and prevention of eclampsia in women with severe pre-eclampsia  In settings where the full dosage of magnesium sulfate cannot be administered, a loading dose followed by immediate transfer to an appropriate facility is recommended  Women with severe hypertension in pregnancy should also be treated with antihypertensive drugs Filename

99 Safe abortion: Technical and policy guidance for health systems  Released 2012  New recommendations on medical abortion and management of incomplete abortion Filename

10 Safe abortion care  Medical abortion regimens up to 24 weeks (either mifepristone + misoprostol or misoprostol alone)  Treatment of incomplete abortion with vacuum aspiration or misoprostol  Abortion can be safely provided by non-physician clinicians when appropriately trained and supported Filename

11 Innovations for Humanitarian Settings: Sexual and Reproductive Health Technologies  Co-hosted by Gynuity Health Projects, The IFRC and WHO Department of Reproductive Health and Research  Purpose: Share recent updates in WHO guidance and discuss evidence-based reproductive health technologies 11

12 Oxytocics  The use of uterotonics for the prevention of PPH during the third stage of labour is recommended for all births.  Oxytocin (10 IU, IV/IM) is the recommended uterotonic drug for the prevention of PPH.  In settings where oxytocin is unavailable, the use of other injectable uterotonics (if appropriate ergometrine/methylergometrine or the fixed drug combination of oxytocin and ergo- metrine) or oral misoprostol (600 μg) is recommended.  In settings where skilled birth attendants are not present and oxytocin is unavailable, the administration of misoprostol (600 μg PO) by community health care workers and lay health workers is recommended for the prevention of PPH. Filename

13 Controlled cord traction  In settings where skilled birth attendants are available, CCT is recommended for vaginal births if the care provider and the parturient woman regard a small reduction in blood loss and a small reduction in the duration of the third stage of labour as important  In settings where skilled birth attendants are unavailable, CCT is not recommended. Filename

14 Cord clamping  Late cord clamping (performed after 1 to 3 minutes after birth) is recommended for all births while initiating simultaneous essential newborn care. (Strong recommendation, moderate- quality evidence)  Early cord clamping (<1 minute after birth) is not recommended unless the neonate is as- phyxiated and needs to be moved immediately for resuscitation. (Strong recommendation, moderate- quality evidence) Filename

15 Uterine care  Sustained uterine massage is not recommended as an intervention to prevent PPH in women who have received prophylactic oxytocin.  Postpartum abdominal uterine tonus assessment for early identification of uterine atony is recommended for all women. Oxytocin (IV or IM) is the recommended uterotonic drug for the prevention of PPH in c/section.  Controlled cord traction is the recommended method for removal of the placenta in caesarean section… Filename